| Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial | |
| Zhang, Wei; Gao, Yuhuan; Jin, Zhengming; Zhou, Jianfeng; Jin, Chuan; Zou, Liqun; Qiu, Lugui; Li, Wei; Yang, Jianmin; Hou, Ming | |
| 刊名 | LANCET HAEMATOLOGY
 |
| 2019 | |
| 卷号 | 6期号:1 |
| ISSN号 | 2352-3026 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3534857 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Zhang, Wei,Gao, Yuhuan,Jin, Zhengming,et al. Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial[J]. LANCET HAEMATOLOGY,2019,6(1). |
| APA | Zhang, Wei.,Gao, Yuhuan.,Jin, Zhengming.,Zhou, Jianfeng.,Jin, Chuan.,...&Qian, Wenbin.(2019).Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial.LANCET HAEMATOLOGY,6(1). |
| MLA | Zhang, Wei,et al."Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial".LANCET HAEMATOLOGY 6.1(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论